Tenofovir cuts HIV infection risk in injection drug users

06/13/2013 | HealthDay News

Researchers tracked more than 2,400 injection drug users in Thailand and found that daily intake of the antiviral drug tenofovir was associated with an almost 49% lower risk of HIV infection. Patients who most closely adhered to the prescribed regimen benefited the most from tenofovir's protective effect. The findings were reported in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA